• Dr.Sreena T I
• Dr.Sunita D.Ram
• Dr. Nripendra Mishra

In Ayurveda, one of the major controversies is related to identification of a drug of herbal origin creating hurdles for pharmacopoeial standards of the formulations. Controversial plants or sandigda dravyas of vanaspathi have their roots in the past. Due to polynomial nomenclature system of medicinal plant names in Sanskrit texts, each classical plant is attributed with many botanical sources. Also nowadays physicians lost their traditional link and were less exposed to field identification, these leads to a reduction in their knowledge. All these may give rise to controversies in identification of plants. Proper documentation of controversial drugs and discussion with experts in Pharmacognosy, pharmacology, traditional vaidyas, tribal etc. (a multifaceted study needed) are some steps to get clear these controversies.

Controversy, Sandigda dravya, Rasna

"A Review on Controversy in Medicinal Plants.", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.9, Issue 6, page no.j442-j447, June-2022, Available :http://www.jetir.org/papers/JETIR2206959.pdf

"A Review on Controversy in Medicinal Plants.", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.9, Issue 6, page no. ppj442-j447, June-2022, Available at : http://www.jetir.org/papers/JETIR2206959.pdf